Cargando…
Small Molecule Antagonists of the Nuclear Androgen Receptor for the Treatment of Castration-Resistant Prostate Cancer
[Image: see text] After a high-throughput screening campaign identified thioether 1 as an antagonist of the nuclear androgen receptor, a zone model was developed for structure–activity relationship (SAR) purposes and analogues were synthesized and evaluated in a cell-based luciferase assay. A novel...
Autores principales: | Johnson, James K., Skoda, Erin M., Zhou, Jianhua, Parrinello, Erica, Wang, Dan, O’Malley, Katherine, Eyer, Benjamin R., Kazancioglu, Mustafa, Eisermann, Kurtis, Johnston, Paul A., Nelson, Joel B., Wang, Zhou, Wipf, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2016
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983742/ https://www.ncbi.nlm.nih.gov/pubmed/27563404 http://dx.doi.org/10.1021/acsmedchemlett.6b00186 |
Ejemplares similares
-
The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer
por: Eisermann, Kurtis, et al.
Publicado: (2017) -
Androgen receptor gene mutation, rearrangement, polymorphism
por: Eisermann, Kurtis, et al.
Publicado: (2013) -
Poly (A) Binding Protein Cytoplasmic 1 Is a Novel Co-Regulator of the Androgen Receptor
por: Eisermann, Kurtis, et al.
Publicado: (2015) -
Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer
por: Myung, Jae-Kyung, et al.
Publicado: (2017) -
Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site
por: Eisermann, Kurtis, et al.
Publicado: (2013)